Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.
Insider NameBuy/SellCompany NameTickerAmountShares Change
Sep 02, 2021Sep 07, 2021Pierce Christopher
EVP
Chief of Business Oper
SellPrelude Therapeutics IncPRLD$41.68$708,493-81.93%
Apr 29, 2021Apr 30, 2021Pierce Christopher
EVP
Chief of Business Oper
SellPrelude Therapeutics IncPRLD$40.29$132,765-46.77%
Apr 08, 2021Apr 15, 2021Pierce Christopher
EVP
Chief of Business Oper
SellPrelude Therapeutics IncPRLD$40$8,000-5.06%
Apr 07, 2021Apr 09, 2021Pierce Christopher
EVP
Chief of Business Oper
SellPrelude Therapeutics IncPRLD$40.08$33,188-18.09%
Sep 29, 2020Sep 30, 2020Pierce Christopher
EVP
Chief of Business Oper
BuyPrelude Therapeutics IncPRLD$19$71,250+50.00%